SHFH — Scientist Home Future Health Ltd
—
OTC ·
Materials ·
Chemicals ·
CIK 2032609 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 211,984 | 121,020 | 8,212 | 8,212 | 607,898 | 13,653 | 686,103 |
| Jun 2026 | 84,303 | 29,109 | -97,852 | -97,852 | 529,844 | 9,047 | 616,168 |
| Mar 2026 | 188,756 | 59,068 | -102,072 | -102,072 | 558,759 | 15,332 | 547,332 |
| Dec 2025 | 88,075 | 32,589 | -152,726 | -152,726 | 644,365 | 68,888 | 530,974 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-322,808
Investing CF
—
Financing CF
$298,286
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.00
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-446,629
Inventory
$33,898
Receivables
—
ST Investments
—
EBIT TTM
$-400,495
Pretax Income TTM
$-400,495
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$400,738
EBITDA
—
Free Cash Flow
—
Enterprise Value
$244,617,184
Total Cash
$9,047
Total Debt
$351,435
Shares Out
23,716,000
Trailing EPS
$-0.02
Book Value
$0.01
ROE
—
ROA
—
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 204,055 | -231,725 | -231,725 | 644,365 | 530,974 | 113,391 | -248,278 |
| Dec 2024 | — | — | — | 21,248 | 27,268 | -6,020 | — |
TTM Snapshot
Revenues TTM
$149,975
NetIncome TTM
$-400,495
OpCashFlow TTM
—
Assets (Latest)
$529,844
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PG | PROCTER & GAMBLE Co | $398.01B | $171.72 | — |
| LIN | LINDE PLC | $236.48B | $515.11 | — |
| UL | UNILEVER PLC | $140.63B | $65.31 | — |
| ECL | ECOLAB INC. | $84.87B | $302.59 | — |
| CL | COLGATE PALMOLIVE CO | $79.18B | $99.61 | — |
News headlines (Yahoo Finance, 1h cache)
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
2026-09-10 11:42 · Yahoo
Scientist Home Future Health Reports Second Quarter 2026 Financial Results
2026-09-02 19:52 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.